scils lab software 2022a (Bruker Corporation)
Bruker Corporation is a verified supplier 
Bruker Corporation manufactures this product 
97
Structured Review
Bruker Corporation
scils lab software 2022a
Scils Lab Software 2022a, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 851 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scils+lab+software+2022a/SCiLS+Lab/us12566180-451-41-45
Average 97 stars, based on 851 article reviews
Scils Lab Software 2022a, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 851 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scils+lab+software+2022a/SCiLS+Lab/us12566180-451-41-45
Average 97 stars, based on 851 article reviews
scils lab software 2022a - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Produced:Article Title: Acute Lyme disease IgG N-linked glycans contrast the canonical inflammatory signature Article Snippet: In brief, 1μL serum diluted in 99μL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Lyme Disease IgG N-linked Glycans Contrast the Canonical Inflammatory Signature Article Snippet: In brief, serum samples incubated with 0.2μg/μl spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Article Snippet: In brief, 1mL serum diluted in 99mL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release Nglycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Glycoproteomics:Article Title: Acute Lyme disease IgG N-linked glycans contrast the canonical inflammatory signature Article Snippet: In brief, 1μL serum diluted in 99μL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Lyme Disease IgG N-linked Glycans Contrast the Canonical Inflammatory Signature Article Snippet: In brief, serum samples incubated with 0.2μg/μl spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Article Snippet: In brief, 1mL serum diluted in 99mL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release Nglycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Software:Article Title: Acute Lyme disease IgG N-linked glycans contrast the canonical inflammatory signature Article Snippet: In brief, 1μL serum diluted in 99μL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Lyme Disease IgG N-linked Glycans Contrast the Canonical Inflammatory Signature Article Snippet: In brief, serum samples incubated with 0.2μg/μl spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80-104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release N-glycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using Article Title: Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Article Snippet: In brief, 1mL serum diluted in 99mL 1X PBS was incubated with 0.2mg/ml spotted anti-IgG capture antibodies (Bethyl Laboratories Inc., Tx, Cat. .. Number A80104) treated with Sialidase A (produced in-house by MUSC), sprayed with PNGase F (produced by N-Zyme, PA) to release Nglycans from captured targets, coated with a matrix, and analyzed for glycan abundance at specific m/z peaks by MALDI-FT-ICR MS using other:Article Title: Methods of diagnosing or treating Lyme disease Article Snippet: MALDI-FT-ICR Mass Spectrometry N-Glycan Analysis SolarisX Legacy 7T FT-ICR mass spectrometer equipped with a |
![Figure 7. Comparison of the spatial distribution of naloxone (sodium adduct ion (m/z 350.136) and potassium adduct ion (m/z 366.110)) inside ZF larval whole body between (a,b) the protocol used in the previous studies [26,27] and (c,d) the optimal condition investigated in this study. All MS images were visualized with a three-dimensional view function in SCiLS Lab version <t>2022a</t> Premium 3D software, based on the diagram of a ZF larva shown in Figure 4. The experimental conditions were the following: (a,b) 14 passes of spraying matrix deposition using 15 mg mL−1 DHB containing 0.1% TFA and 40% gelatin embedding medium, a total of 10 slides for one respective larva; (c,d) 8 passes of spraying matrix deposition using 5 mg mL−1 CHCA containing 0.1% TFA and 40% gelatin embedding medium, a total of 11 slides for one respective larva. The images were generated by preparing a color map from blue (no detection) to yellow (high local concentration) with a 50% transparency option, and then they were further processed in 96 dpi resolution with 24-bit color under a denoising state. The red lines indicate individual larval body sections that were overlapped for 3D visualization, and approximately 15 sections were usually utilized for this visualization.](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_3226/pm37373226/pm37373226__page12_image1.jpg)
